These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 7599575

  • 21. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C, Koç H, Karayalcin S, Akyol G, Gürman G, Ilhan O, Akan H, Ozcan M, Arslan O, Konuk N, Uysal A, Beksaç M.
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [Abstract] [Full Text] [Related]

  • 22. IGIV: a potential role for hepatitis B prophylaxis in the bone marrow peritransplant period.
    Daily J, Werner B, Soiffer R, Fingeroth J.
    Bone Marrow Transplant; 1998 Apr; 21(7):739-42. PubMed ID: 9578318
    [Abstract] [Full Text] [Related]

  • 23. Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
    Hashino S, Nozawa A, Izumiyama K, Yonezumi M, Chiba K, Kondo T, Suzuki S, Hige S, Asaka M.
    Bone Marrow Transplant; 2002 Feb; 29(4):361-3. PubMed ID: 11896435
    [Abstract] [Full Text] [Related]

  • 24. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B, Jilg W, Buchholz L, Stremmel W, Engler S.
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [Abstract] [Full Text] [Related]

  • 25. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B.
    Vaccine; 2004 Sep 28; 22(29-30):3963-7. PubMed ID: 15364445
    [Abstract] [Full Text] [Related]

  • 26. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 28; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 27. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL, Smith V, Sands M.
    Int J Infect Dis; 2008 Nov 28; 12(6):e77-83. PubMed ID: 18723381
    [Abstract] [Full Text] [Related]

  • 28. [Kinetics of vaccination antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogenic and autologous bone marrow transplantation and booster vaccination. 2: Kinetics of vaccination antibodies against diphtheria toxoid after allogenic and autologous bone marrow transplantation].
    Prager J, Thilo W, Hermann J, Fuchs D, Zintl F.
    Kinderarztl Prax; 1992 Oct 28; 60(7):195-8. PubMed ID: 1434337
    [Abstract] [Full Text] [Related]

  • 29. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
    Kaloyannidis P, Batsis I, Yannaki E, Adamidou D, Bartzoudis D, Papathanasiou M, Mallouri D, Sakellari I, Fassas A, Anagnostopoulos A.
    Biol Blood Marrow Transplant; 2007 Sep 28; 13(9):1049-56. PubMed ID: 17697967
    [Abstract] [Full Text] [Related]

  • 30. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.
    Idilman R, Colantoni A, De Maria N, Ustun C, Sam R, Ing TS, Akan H, Koc H, Van Thiel DH.
    Hepatogastroenterology; 2003 Sep 28; 50(49):217-21. PubMed ID: 12630026
    [Abstract] [Full Text] [Related]

  • 31. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM, Saunders EF, Petric M, Gold R.
    Bone Marrow Transplant; 1996 Apr 28; 17(4):633-6. PubMed ID: 8722367
    [Abstract] [Full Text] [Related]

  • 32. Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients.
    Gentile G, Capobianchi A, Volpi A, Palù G, Pica F, Calistri A, Biasolo MA, Martino P.
    J Natl Cancer Inst; 2005 Jul 06; 97(13):1008-11. PubMed ID: 15998954
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of accelerated hepatitis B vaccination program in patients being actively treated for hematologic malignancies.
    Pullukcu H, Ertem E, Karaca Y, Yamazhan T, Sertoz RY, Altuglu I.
    Int J Infect Dis; 2008 Mar 06; 12(2):166-70. PubMed ID: 17720599
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T, Günther M, Bienzle U, Neuhaus R, Jilg W.
    Liver Transpl; 2007 Mar 06; 13(3):434-42. PubMed ID: 17318860
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.